BIOY vs IVV
GraniteShares YieldBOOST Biotech ETF vs iShares Core S&P 500 ETF
Quick Verdict
IVV has a lower expense ratio. IVV offers more diversification with 508 holdings.
Side-by-Side Comparison
| Metric | BIOY | IVV | Winner |
|---|---|---|---|
| Expense Ratio | 1.07% | 0.03% | |
| AUM | $846,320.22 | $907.0B | |
| Dividend Yield | 16.47% | 1.10% | |
| Holdings | 0 | 508 | |
| YTD Return | +0.38% | +12.71% | |
| 1Y Return | - | +21.89% | |
| 3Y Return (annualized) | - | +22.08% | |
| 5Y Return (annualized) | - | +12.96% | |
| Volatility (annualized) | - | 15.1% | |
| Max Drawdown | -6.6% | -56.5% | |
| Fund Family | GraniteShares | iShares by BlackRock (US) | |
| Category | Alternative | Equity | |
| Inception | May 6, 2026 | May 15, 2000 |
BIOY vs IVV Performance
GraniteShares YieldBOOST Biotech ETF (BIOY) is a ETF from GraniteShares and iShares Core S&P 500 ETF (IVV) is a ETF from iShares by BlackRock (US). Year to date, BIOY is up 0.38% versus a gain of 12.71% for IVV.
Risk: Volatility and Drawdowns
The deepest peak-to-trough decline in our data was -6.6% for BIOY and -56.5% for IVV. Drawdown depth is worth weighing if you expect to sell during market stress rather than ride it out.
Fees and Cost Over Time
BIOY charges 1.07% per year while IVV charges 0.03%. On a $10,000 position that is $107 vs $3 annually, a gap of $104 per year that compounds over a long holding period. On income, BIOY currently yields 16.47% against 1.10% for IVV.
Frequently Asked Questions
Which is cheaper, BIOY or IVV?
BIOY has an expense ratio of 1.07% while IVV charges 0.03%. IVV is the cheaper option. On a $10,000 investment, that is $104 per year of difference.
Which pays a higher dividend, BIOY or IVV?
BIOY yields 16.47% while IVV yields 1.10%, so BIOY currently pays the higher dividend yield.
Popular ETF Comparisons
Get Full ETF Analytics
Access complete holdings data, overlap analysis, screener tools, and more with FundXLS.